Perrigo Sales Up 39% On Big Brand Equivalents, Firm Expects Big Box Boost

Perrigo reached record growth in its latest quarter on the launches of Prilosec OTC and Zyrtec equivalents, and the private-labeler's momentum will likely build further as market conditions ripen for store brand success

More from Archive

More from Pink Sheet